Publication | Closed Access

TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)

Malignant DiseaseMedicinePathologyGerman Scchn GroupHead And Neck CancerNeck OncologyOncologyRadiation OncologyCancer Research